Clinical Evidence

Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers missed by mammography.  Invenia ABUS is designed for the screening environment, specifically for dense breast imaging.  Invenia ABUS diminishes operator variability and creates 3D ultrasound volumes to enable comprehensive analysis and comparison to multi-modality exams. 

Read the SomoInsight Study, to learn about the effectiveness of ABUS for breast screening. Download the SomoInsight Study 


Dr. Rachel Brem comments on the significance of the study Dr. Mark Inciardi comments on the clinical benefit of ABUS



Case Studies

Download the case studies at the right detailing how ABUS helped uncover hidden cancers.


View clinical images and cases


Clinical Images

View clinical images


Complimentary webinars

View webinars by ABUS early adopters as they discuss their experience and results. Additional complimentary webinars are also available.  

Customer and Patient Experience

Click here listen to clinicians speak about their experience using ABUS in their practice, and patients speaking about the peace of mind ABUS brings.









Webinars

These complimentary webinars feature experienced ABUS users who discuss ABUS in clinical practice.

Developing a Personalized Breast Screening Program

Dr. Joseph Russo, Section Chief of Women's Imaging, St. Luke's University Health Network, Bethlehem, PA
This presentation outlines an effective way to manage screening in the 'dense breast era' through the development of a personalized screening program utilizing various imaging modalities based on a woman's risk and breast density. 




Dense Breast Tissue: Status of Ultrasound for Breast Cancer Screening

Marc F Inciardi, MD, Assistant Professor of Radiology, Section Head, Breast Imaging, University of Kansas Medical Center
What is breast density? Why it is important to measure?  What is its role as an independent risk factor for developing breast cancer? What is its impact on the effectiveness of screening mammography.? Dr. Marc Inciardi will review University of Kansas clinical results using automated breast ultrasound since 2009 for screening women with dense breasts as one of the 12 clinical sites participating in the SomoInsight Clinical Study.




Implementation of ABUS in the Community Setting

Monica H Saini MD, MS, Chief of Breast Imaging, Santa Fe Imaging/Christus Medical Center
This presentation reviews the decrease in sensitivity of mammography in dense breasts and the risk associated with breast density.  Published clinical results supporting supplemental screening with Automated Breast Ultrasound (ABUS) are featured.  Dr. Sani presents her first year experiences in implementing ABUS in a community hospital as a supplemental screening tool for women with dense breasts and reviews interesting ABUS cases.





Screening Ultrasound

Ian Grady MD, FACS, North Valley Breast Center, Redding, CA
A brief history of various publications supporting the use of handheld ultrasound and Automated Breast Ultrasound (ABUS) as a supplemental screening tool for the dense breast population will be presented.  In addition, the integration of ABUS into the breast screening workflow will be explained and various clinical examples will be reviewed.




Automated Breast Sonographic Coronal Imaging: Diagnostic and Screening Applications

Beverly E Hashimoto, M.D., FACR, Section Head, Ultrasound, Virginia Mason Medical Center, Seattle, WA
This presentation covers coronal breast scanning and its ability to offer operator independent acquisition, wide field of view, and provide an excellent basis for multi-modality comparisons.  Dr. Beverly Hashimoto will review various clinical cases that demonstrate the benefit of the coronal view for breast imaging.



These complementary webinars provide healthcare professionals and introduction to ABUS and the clinical need for this technology.

Introduction to Automated Breast Ultrasound for Screening Women with Dense Breasts

Jackie Bailey, Senior Clinical Product Manager.
This webinar will discuss current breast cancer statistics, current breast cancer screening practice in the USA and the challenge of screening dense breasts.  Mammography can miss 1/3 of cancer in dense breasts, and over 40% of American Women have dense breasts.  An overview of Automated Breast Ultrasound (ABUS) will be provided and examples of how this technology can be integrated into daily clinical practice for supplemental screening for women with dense breasts.




Breast Density: The Radiologic Dilemma

Jessie Jacob, MD, MMM Medical Director, Northern California Women's Imaging Center.
This insightful presentation from a radiologist’s perspective informs about the challenges radiologists encounter when interpreting dense breast exams. The presentation also includes current dense breast research and an overview of screening options for women with dense breasts.  Case reviews of dense breast patients demonstrate the radiologic dilemma by comparing mammograms and Automated Breasts Ultrasound (ABUS) exams.

Testimonials

ABUS users provide their commentary on the clinical need for supplemental screening for dense breasts, and how ABUS has performed in clinical practice.

Clinician Experience

The clinical need for ABUS
What should be done for patients with dense breasts?
How does ABUS benefit surgeons?
Invenia ABUS patient experience

Patient Experience

Patient’s provide their impressions of ABUS supplemental screening for dense breasts, and how it has affected them.  For more information on breast care for patients, please visit 

ABUS peace of mind
Joyce’s story
Carol’s story
Michelle’s story

Clinical Images

Invenia ABUS images and cases

Below are cases of ABUS clinical images and cases. Images can be viewed in multiple hanging protocols. Click here for a brief overview of the anatomy of an ABUS image.


IDC grade 2 lesion with mammography

Multi-focal biopsy proven invasive ductal carcinoma


Multiple fibroadenomas

Dense tissue – normal duct


Biopsy proven invasive ductal carcinoma with multiple satellite lesions


Extremely dense tissue – normal study


Biopsy proven fibroadenoma

 

Case 45 - 82 yr. old - Annual screening mammographically occult IDC





 

Case 46 - 54 yr. old – left palpable – IDC incidental finding right lobular carcinoma







 

Case 47 - 56 yr old - Annual screening mammographically occult IDC









Biopsy proven IDC shown with Invenia ABUS, hand-held ultrasound, mammography and MRI

Anatomy of an ABUS Image

Anatomy of an ABUS Image
The appearance of an ABUS image may seem unfamiliar at first. The 4 quadrant, multi-image format allows clinicians great flexibility to investigate various views of tissue or suspicious areas in one display.  A collection of orientation tools also help clinicians identify their location and navigate through the tissue.


  1. Dual volume display (coronal transverse side by side) allows comparison within the same ABUS exam, or with other modality exams.
  2. Coronal view from skin line to chest wall is adjustable from 0.5 – 10 mm thickness  (increments of 0.5 mm). 
  3. Axial view is adjustable from 0.5 –  10 mm thickness  (increments of 0.5 mm) 
  4. Nipple marker in each coronal image remains in view to provide constant orientation 
  5. Breast body marker in each quadrant displays the three coordinates of the current region of interest position (clock, distance from nipple and depth from the skin) thus providing a very precise location of the lesion. This body marker information helps in targeting the area very quickly with the hand held ultrasound, which is necessary when performing follow-ups on suspicious findings on the Invenia ABUS. 



  6. Image orientation graphic in each quadrant shows the anatomical location of the volume The graphic is configurable and the lettering represents the anatomical orientations: Anterior, Posterior, Medial, Lateral, Superior and Inferior.